A clinical approach to inherited premature coronary artery disease

Circulation: Cardiovascular Genetics

Volumn 7, Issue 4, 2014, Pages 558-564

  Stitziel, Nathan O ^a,b   MacRae, Calum A ^c  

^a Department of Medicine   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Coronary artery disease; Genetic testing; Genetics; Myocardial infarction

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; ACTA2 PROTEIN, HUMAN; ACTIN; LDLR PROTEIN, HUMAN;

AGE; ARTICLE; ATHEROSCLEROSIS; AUTOSOMAL DOMINANT INHERITANCE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HEART INFARCTION; HERITABILITY; HUMAN; HYPERCHOLESTEROLEMIA; INHERITED PREMATURE CORONARY ARTERY DISEASE; INHERITED PREMATURE MYOCARDIAL INFARCTION; MONOGENIC DISORDER; MUCOCUTANEOUS LYMPH NODE SYNDROME; PEDIGREE; PENETRANCE; PRIORITY JOURNAL; SEX DIFFERENCE; WILLIAMS BEUREN SYNDROME; ADULT; ELECTROCARDIOGRAPHY; FEMALE; GENETICS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; PHENOTYPE;

ACTINS; ADULT; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; PEDIGREE; PHENOTYPE; RECEPTORS, LDL;

EID: 84925945275     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000152     Document Type: Article

References (50)

1. Thomas CB, Cohen BH. The familial occurrence of hypertension and coronary artery disease, with observations concerning obesity and diabetes. Ann Intern Med. 1955;42:90-127
2. White PD. Genes, the heart and destiny. N Engl J Med. 1957;256:965-969
3. Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nat Rev Genet. 2002;3:872-882
4. Nora JJ, Lortscher RH, Spangler RD, Nora AH, Kimberling WJ. Genetic-epidemiologic study of early-onset ischemic heart disease. Circulation. 1980;61:503-508
5. Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, et al. Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation. 2005;111:855-862.
6. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: A 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252:247-254
7. Visscher PM, Hill WG, Wray NR. Heritability in the genomics era-concepts and misconceptions. Nat Rev Genet. 2008;9:255-266
8. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47
9. Soutar AK, Naoumova RP. Autosomal recessive hypercholesterolemia. Semin Vasc Med. 2004;4:241-248
10. Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet. 2003;34:154-156
11. Soria LF, Ludwig EH, Clarke HR, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989;86:587-591
12. Marcil M, Boucher B, Krimbou L, Solymoss BC, Davignon J, Frohlich J, et al. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization. Arterioscler Thromb Vasc Biol. 1995;15:1015-1024
13. Schreibman PH, Wilson DE, Arky RA. Familial type IV hyperlipoproteinemia. N Engl J Med. 1969;281:981-985
14. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 2003;302:1578-1581
15. Weng L, Kavaslar N, Ustaszewska A, Doelle H, Schackwitz W, Hébert S, et al. Lack of MEF2A mutations in coronary artery disease. J Clin Invest. 2005;115:1016-1020
16. Altshuler D, Hirschhorn JN. MEF2A sequence variants and coronary artery disease: A change of heart? J Clin Invest. 2005;115:831-833
17. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 2007;315:1278-1282
18. Williams JC, Barratt-Boyes BG, Lowe JB. Supravalvular aortic stenosis. Circulation. 1961;24:1311-1318
19. Pober BR. Williams-Beuren syndrome. N Engl J Med. 2010;362:239-252
20. Conway EE Jr, Noonan J, Marion RW, Steeg CN. Myocardial infarction leading to sudden death in the Williams syndrome: report of three cases. J Pediatr. 1990;117:593-595
21. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980;140:233-236
22. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-Actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617-627
23. Roifman I, Therrien J, Ionescu-Ittu R, Pilote L, Guo L, Kotowycz MA, et al. Coarctation of the aorta and coronary artery disease: Fact or fiction? Circulation. 2012;126:16-21
24. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37:1-31
25. Bercovitch L, Terry P. Pseudoxanthoma elasticum 2004. J Am Acad Dermatol. 2004;51(1 suppl):S13-S14
26. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, et al. Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet. 2000;25:228-231
27. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271-276
28. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Longterm consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385
29. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40:35-42
30. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al; Hong Kong-Shanghai Kawasaki Disease Genetics Consortium; Korean Kawasaki Disease Genetics Consortium; Taiwan Kawasaki Disease Genetics Consortium; International Kawasaki Disease Genetics Consortium; US Kawasaki Disease Genetics Consortium; Blue Mountains Eye Study. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011;43:1241-1246
31. Khor CC, Davila S, Shimizu C, Sheng S, Matsubara T, Suzuki Y, et al; US and International Kawasaki Disease Genetics Consortia. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet. 2011;48:467-472
32. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA. 1997;277:1305-1307
33. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999-1004
34. Varga EA, Kujovich JL. Management of inherited thrombophilia: Guide for genetics professionals. Clin Genet. 2012;81:7-17
35. Sherer Y, Shoenfeld Y. Mechanisms of disease: Atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol. 2006;2:99-106
36. Online Mendelian Inheritance in Man. OMIM®. Mckusick-nathans institute of genetic medicine, Johns Hopkins University. Available at: http://www.omim.org. Accessed July 20, 2014
37. Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: A critical review. Haemophilia. 2006;12:345-351
38. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 2007;316:1491-1493
39. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007;316:1488-1491
40. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-678
41. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet. 2011;43:339-344
42. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009;41:334-341
43. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al; WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443-453
44. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333-338
45. Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33
46. Ripatti S, Tikkanen E, Orho-Melander M, Havulinna AS, Silander K, Sharma A, et al. A multilocus genetic risk score for coronary heart disease: Casecontrol and prospective cohort analyses. Lancet. 2010;376:1393-1400
47. Global Lipids Genetics Consortium, Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274-1283
48. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358:1240-1249
49. Ganesh SK, Arnett DK, Assimes TL, Basson CT, Chakravarti A, Ellinor PT, et al; American Heart Association Council on Functional Genomics and Translational Biology; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Basic Cardiovascular Sciences; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Cardiovascular and Stroke Nursing; American Heart Association Stroke Council. Genetics and genomics for the prevention and treatment of cardiovascular disease: Update: A scientific statement from the American Heart Association. Circulation. 2013;128:2813-2851
50. Akosah KO, Gower E, Groon L, Rooney BL, Schaper A. Mild hypercholesterolemia and premature heart disease: Do the national criteria underestimate disease risk? J Am Coll Cardiol. 2000;35:1178-1184.